Cargando…
Ultrastructural Characterization of Human Bronchial Epithelial Cells during SARS-CoV-2 Infection: Morphological Comparison of Wild-Type and CFTR-Modified Cells
SARS-CoV-2 replicates in host cell cytoplasm. People with cystic fibrosis, considered at risk of developing severe symptoms of COVID-19, instead, tend to show mild symptoms. We, thus, analyzed at the ultrastructural level the morphological effects of SARS-CoV-2 infection on wild-type (WT) and F508de...
Autores principales: | Merigo, Flavia, Lotti, Virginia, Bernardi, Paolo, Conti, Anita, Clemente, Andrea Di, Ligozzi, Marco, Lagni, Anna, Sorio, Claudio, Sbarbati, Andrea, Gibellini, Davide |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9455986/ https://www.ncbi.nlm.nih.gov/pubmed/36077122 http://dx.doi.org/10.3390/ijms23179724 |
Ejemplares similares
-
CFTR Modulation Reduces SARS-CoV-2 Infection in Human Bronchial Epithelial Cells
por: Lotti, Virginia, et al.
Publicado: (2022) -
WS05.04 SARS-CoV-2 infection is reduced in both immortalised and primary CFTR-modulated human bronchial epithelial cells
por: Lotti, V., et al.
Publicado: (2022) -
439 Cystic fibrosis transmembrane conductance regulator impairment strongly decreases SARS-CoV-2 replication in human bronchial epithelial cells
por: Sorio, C., et al.
Publicado: (2022) -
CFTR Inhibitors Display In Vitro Antiviral Activity against SARS-CoV-2
por: Lagni, Anna, et al.
Publicado: (2023) -
Crosslink between SARS-CoV-2 replication and cystic fibrosis hallmarks
por: Lotti, Virginia, et al.
Publicado: (2023)